71
Growth Score
pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
326978
A28 Therapeutics develops targeted lytic peptide treatments for multiple cancer types, focusing on innovative cancer care.
About the Company
A28 Therapeutics is a clinical stage biopharmaceutical company focused on developing innovative treatments for various cancer types. It specializes in a novel platform technology centered around targeted lytic peptides, aiming to offer new therapeutic options for cancer patients. The company's research includes exploring the potential of
AT-101 in combination with immuno-oncology therapeutics for solid tumors with liver metastases. With a team of dedicated professionals, A28 Therapeutics is committed to advancing cancer treatment through its pioneering work in biotechnology.
